Table 1.

The upregulated DEPs between mGC patients group and healthy controls group.

No.	Protein accession	Gene name	mGC/HC Ratio	No.	Protein accession	Gene name	mGC/HC Ratio
1	O14818	PSMA7	2.08	33	P04180	LCAT	Inf+
2	P00738	HP	2.13	34	P04211	IGLV7-43	Inf+
3	Q9Y251	HPSE	2.13	35	P08311	CTSG	Inf+
4	P02750	LRG1	2.35	36	P08709	F7	Inf+
5	P59666	DEFA3	2.38	37	P08758	ANXA5	Inf+
6	P30626	SRI	2.45	38	P0DJI8	SAA1	Inf+
7	P02765	AHSG	2.54	39	P11678	EPX	Inf+
8	A0A075B6I0	IGLV8-61	2.60	40	P20618	PSMB1	Inf+
9	P05164	MPO	2.61	41	P25786	PSMA1	Inf+
10	P02786	TFRC	2.70	42	P25788	PSMA3	Inf+
11	P68431	HIST1H3A	2.79	43	P25789	PSMA4	Inf+
12	P02671	FGA	2.84	44	P28066	PSMA5	Inf+
13	Q99880	HIST1H2BL	2.89	45	P28072	PSMB6	Inf+
14	P20742	PZP	2.97	46	P35443	THBS4	Inf+
15	P06681	C2	3.14	47	P49913	CAMP	Inf+
16	P22891	PROZ	3.30	48	P54108	CRISP3	Inf+
17	Q99878	HIST1H2AJ	3.69	49	P55058	PLTP	Inf+
18	P01704	IGLV2-14	4.07	50	P55072	VCP	Inf+
19	P00742	F10	4.42	51	P60900	PSMA6	Inf+
20	P11597	CETP	4.65	52	P62987	UBA52	Inf+
21	P02679	FGG	4.91	53	P80511	S100A12	Inf+
22	P04070	PROC	5.32	54	Q08554	DSC1	Inf+
23	P62805	HIST1H4A	5.33	55	Q08830	FGL1	Inf+
24	P02741	CRP	7.20	56	Q13790	APOF	Inf+
25	P18428	LBP	13.39	57	Q71DI3	HIST2H3A	Inf+
26	A0A087WW87	IGKV2-40	Inf+	58	Q8NEZ4	KMT2C	Inf+
27	A0A0C4DH33	IGHV1-24	Inf+	59	Q8WUJ3	CEMIP	Inf+
28	O00560	SDCBP	Inf+	60	Q8WXI7	MUC16	Inf+
29	O00602	FCN1	Inf+	61	Q9HC84	MUC5B	Inf+
30	O95810	CAVIN2	Inf+	62	Q9NZP8	C1RL	Inf+
31	P01721	IGLV6-57	Inf+	63	Q9NZT1	CALML5	Inf+
32	P02042	HBD	Inf+	64	Q9Y2I7	PIKFYVE	Inf+

mGC, metastatic gastric cancer; HC, healthy controls; DEPs, differentially expressed proteins; Inf+, infinity.